Endoscopic lung volume reduction with endobronchial valves in very low
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
30
06
2020
accepted:
23
09
2020
entrez:
3
2
2021
pubmed:
4
2
2021
medline:
4
2
2021
Statut:
epublish
Résumé
Endoscopic lung volume reduction (ELVR) with valves has been suggested to be the key strategy for patients with severe emphysema and concomitant low diffusing capacity of the lung for carbon monoxide ( We assessed In total, 121 patients treated with ELVR were analysed. Thirty-four patients with a ELVR improves lung function as well as quality of life in patients with
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic lung volume reduction (ELVR) with valves has been suggested to be the key strategy for patients with severe emphysema and concomitant low diffusing capacity of the lung for carbon monoxide (
METHODS
METHODS
We assessed
RESULTS
RESULTS
In total, 121 patients treated with ELVR were analysed. Thirty-four patients with a
CONCLUSIONS
CONCLUSIONS
ELVR improves lung function as well as quality of life in patients with
Identifiants
pubmed: 33532454
doi: 10.1183/23120541.00449-2020
pii: 00449-2020
pmc: PMC7836438
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright ©ERS 2021.
Déclaration de conflit d'intérêts
Conflict of interest: P. Lenga has nothing to disclose. Conflict of interest: C. Ruwwe-Glösenkamp has nothing do disclose Conflict of interest: C. Grah has nothing to disclose. Conflict of interest: J. Pfannschmidt has nothing to disclose. Conflict of interest: J. Rückert has nothing to disclose. Conflict of interest: S. Eggeling has nothing to disclose. Conflict of interest: S. Gläser reports personal fees from Boehringer Ingelheim, grants and personal fees from Novartis Pharma, and personal fees from Roche Pharma, Berlin Chemie, PneumRx, PulmonX, Actelion Pharma and Bayer Healthcare, outside the submitted work. Conflict of interest: B. Schmidt has nothing to disclose. Conflict of interest: P. Schneider has nothing to disclose. Conflict of interest: S. Kurz has nothing to disclose. Conflict of interest: G. Leschber has nothing to disclose. Conflict of interest: A. Gebhardt has nothing to disclose. Conflict of interest: B. Becke has nothing to disclose. Conflict of interest: O. Schega has nothing to disclose. Conflict of interest: J. Borchardt has nothing to disclose. Conflict of interest: R-H. Hübner reports personal fees and nonfinancial support from PulmonX outside the submitted work.
Références
Eur Respir J. 2005 Sep;26(3):511-22
pubmed: 16135736
Lancet Respir Med. 2019 Apr;7(4):313-324
pubmed: 30744937
Am J Respir Crit Care Med. 2017 May 1;195(9):1272-1274
pubmed: 28459316
Am J Respir Crit Care Med. 2020 Jul 1;202(1):29-50
pubmed: 32023078
Radiology. 2017 Oct;285(1):250-260
pubmed: 28510483
Respiration. 2016;92(4):258-265
pubmed: 27603781
N Engl J Med. 2001 Oct 11;345(15):1075-83
pubmed: 11596586
Am J Respir Crit Care Med. 2016 Nov 1;194(9):1073-1082
pubmed: 27580428
Pneumologie. 2015 Mar;69(3):147-64
pubmed: 25750095
Am J Respir Crit Care Med. 2017 Dec 15;196(12):1535-1543
pubmed: 28885054
Am J Respir Crit Care Med. 2019 Dec 1;200(11):1354-1362
pubmed: 31365298
Eur Respir J. 2015 Dec;46(6):1598-604
pubmed: 26493797
Lancet Respir Med. 2017 Feb;5(2):147-156
pubmed: 27693408
Int J Chron Obstruct Pulmon Dis. 2020 Apr 23;15:871-881
pubmed: 32368033
Respirology. 2020 Sep;25(9):972-980
pubmed: 32363706
Respiration. 2016;92(6):414-419
pubmed: 27838695
N Engl J Med. 2010 Sep 23;363(13):1233-44
pubmed: 20860505
COPD. 2005 Mar;2(1):111-24
pubmed: 17136971
Respiration. 2010;80(5):419-25
pubmed: 20664194
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
Am J Respir Crit Care Med. 1997 Jul;156(1):86-93
pubmed: 9230730
Respiration. 2019;97(6):548-557
pubmed: 30836374
Eur Respir J. 2014 Feb;43(2):387-96
pubmed: 23845721
Respiration. 2015;90(5):402-11
pubmed: 26430783
Respiration. 2020;99(2):163-170
pubmed: 31962325
Eur Respir J. 2005 Oct;26(4):720-35
pubmed: 16204605
Chest. 2008 Oct;134(4):808-14
pubmed: 18842913
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1151-1164
pubmed: 29787288
N Engl J Med. 2015 Dec 10;373(24):2325-35
pubmed: 26650153
Respiration. 2016;92(3):150-7
pubmed: 27577190
Eur Respir J. 2011 Apr;37(4):784-90
pubmed: 20693247
Eur Respir J. 2019 May 18;53(5):
pubmed: 30846476
Ann Thorac Surg. 2018 Feb;105(2):379-385
pubmed: 29223424
Lancet. 2015 Sep 12;386(9998):1066-73
pubmed: 26116485
COPD. 2005 Mar;2(1):75-9
pubmed: 17136966
Eur Respir J. 1993 Mar;6 Suppl 16:41-52
pubmed: 24576916
Eur Respir J. 1991 Feb;4(2):141-6
pubmed: 2044729
BMC Pulm Med. 2018 Dec 6;18(1):187
pubmed: 30522466
Ann Thorac Surg. 2005 Feb;79(2):411-6; discussion 416-7
pubmed: 15680805
Respiration. 2019;97(5):416-427
pubmed: 30554211
Eur Respir J. 2012 Nov;40(5):1137-41
pubmed: 22441742
Semin Respir Crit Care Med. 2020 Dec;41(6):874-885
pubmed: 32434233
Eur Respir Rev. 2019 Apr 17;28(152):
pubmed: 30996040